S1PR1/S1PR3-YAP Signaling and S1P-ALOX15 Signaling Contribute to an Aggressive Behavior in Obesity-lymphoma

Overview

Journal J Exp Clin Cancer Res

Publisher Biomed Central

Specialty Oncology

Date 2023 Jan 4

PMID 36600310

Authors

Xingtong Wang

Wei Guo

Xiaoju Shi

Yujia Chen

Youxi Yu

Beibei Du

Min Tan

Li Tong

Anna Wang

Xianying Yin

Jing Guo

Robert C Martin

Ou Bai

Yan Li

Affiliations

Soon will be listed here.

Abstract

Background: Excess body weight has been found to associate with an increased risk of lymphomas and some metabolic pathways are currently recognized in lymphomagenesis. Bioactive lipid metabolites such as sphingosine-1-phosphate (S1P) have been proposed to play an important role linking obesity and lymphomas. However, the underlying mechanism(s) of S1P signaling in obesity-lymphomagenesis have not been well addressed.

Methods: The gene expression of sphingosine kinase (SPHK), lymphoma prognosis, and S1P production were analyzed using Gene Expression Omnibus (GEO) and human lymphoma tissue array. Obesity-lymphoma mouse models and lymphoma cell lines were used to investigate the S1P/SPHK-YAP axis contributing to obesity-lymphomagenesis. By using the mouse models and a monocyte cell line, S1P-mediated polarization of macrophages in the tumor microenvironment were investigated.

Results: In human study, up-regulated S1P/SPHK1 was found in human lymphomas, while obesity negatively impacted progression-free survival and overall survival in lymphoma patients. In animal study, obesity-lymphoma mice showed an aggressive tumor growth pattern. Both in vivo and in vitro data suggested the existence of S1P-YAP axis in lymphoma cells, while the S1P-ALOX15 signaling mediated macrophage polarization towards TAMs exacerbated the lymphomagenesis. In addition, treatment with resveratrol in obesity-lymphoma mice showed profound effects of anti-lymphomagenesis, via down-regulating S1P-YAP axis and modulating polarization of macrophages.

Conclusion: S1P/S1PR initiated the feedback loops, whereby S1P-S1PR1/S1PR3-YAP signaling mediated lymphomagenesis contributing to tumor aggressive growth, while S1P-ALOX15 signaling mediated TAMs contributing to immunosuppressive microenvironment in obesity-lymphoma. S1P-targeted therapy could be potentially effective and immune-enhancive against obesity-lymphomagenesis.

Citing Articles

Resveratrol-driven macrophage polarization: unveiling mechanisms and therapeutic potential.

Wang P, Li Z, Song Y, Zhang B, Fan C Front Pharmacol. 2025; 15:1516609.

PMID: 39872049 PMC: 11770351. DOI: 10.3389/fphar.2024.1516609.

Spatiotemporal sphingosine-1-phosphate receptor 3 expression within the cerebral vasculature after ischemic stroke.

Matuskova H, Porschen L, Matthes F, Lindgren A, Petzold G, Meissner A iScience. 2024; 27(6):110031.

PMID: 38868192 PMC: 11167442. DOI: 10.1016/j.isci.2024.110031.

Signaling controversy and future therapeutical perspectives of targeting sphingolipid network in cancer immune editing and resistance to tumor necrosis factor-α immunotherapy.

Sukocheva O, Neganova M, Aleksandrova Y, Burcher J, Chugunova E, Fan R Cell Commun Signal. 2024; 22(1):251.

PMID: 38698424 PMC: 11064425. DOI: 10.1186/s12964-024-01626-6.

Lipoxygenases at the Intersection of Infection and Carcinogenesis.

Amoah A, Pestov N, Korneenko T, Prokhorenko I, Kurakin G, Barlev N Int J Mol Sci. 2024; 25(7).

PMID: 38612771 PMC: 11011848. DOI: 10.3390/ijms25073961.

Role for CCN1 in lysophosphatidic acid response in PC-3 human prostate cancer cells.

Balijepalli P, Knode B, Nahulu S, Abrahamson E, Nivison M, Meier K J Cell Commun Signal. 2024; 18(1):e12019.

PMID: 38545253 PMC: 10964937. DOI: 10.1002/ccs3.12019.

References

Inoue C, Sobue S, Mizutani N, Kawamoto Y, Nishizawa Y, Ichihara M . Vaticanol C, a phytoalexin, induces apoptosis of leukemia and cancer cells by modulating expression of multiple sphingolipid metabolic enzymes. Nagoya J Med Sci. 2020; 82(2):261-280. PMC: 7276413. DOI: 10.18999/nagjms.82.2.261. View

Patmanathan S, Wang W, Yap L, Herr D, Paterson I . Mechanisms of sphingosine 1-phosphate receptor signalling in cancer. Cell Signal. 2017; 34:66-75. DOI: 10.1016/j.cellsig.2017.03.002. View

Al-Khami A, Ghonim M, Del Valle L, Ibba S, Zheng L, Pyakurel K . Fuelling the mechanisms of asthma: Increased fatty acid oxidation in inflammatory immune cells may represent a novel therapeutic target. Clin Exp Allergy. 2017; 47(9):1170-1184. PMC: 5578913. DOI: 10.1111/cea.12947. View

Klil-Drori A, Ariel A . 15-Lipoxygenases in cancer: a double-edged sword?. Prostaglandins Other Lipid Mediat. 2013; 106:16-22. DOI: 10.1016/j.prostaglandins.2013.07.006. View

Riboni L, Abdel Hadi L, Navone S, Guarnaccia L, Campanella R, Marfia G . Sphingosine-1-Phosphate in the Tumor Microenvironment: A Signaling Hub Regulating Cancer Hallmarks. Cells. 2020; 9(2). PMC: 7072483. DOI: 10.3390/cells9020337. View

Kelavkar U, Cohen C, Kamitani H, Eling T, Badr K . Concordant induction of 15-lipoxygenase-1 and mutant p53 expression in human prostate adenocarcinoma: correlation with Gleason staging. Carcinogenesis. 2000; 21(10):1777-87. DOI: 10.1093/carcin/21.10.1777. View

Evangelisti C, Buontempo F, Lonetti A, Orsini E, Chiarini F, Barata J . Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies. Leukemia. 2016; 30(11):2142-2151. DOI: 10.1038/leu.2016.208. View

Zhang X, Goncalves R, Mosser D . The isolation and characterization of murine macrophages. Curr Protoc Immunol. 2008; Chapter 14:14.1.1-14.1.14. PMC: 2834554. DOI: 10.1002/0471142735.im1401s83. View

Chang C, Qiu J, OSullivan D, Buck M, Noguchi T, Curtis J . Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression. Cell. 2015; 162(6):1229-41. PMC: 4864363. DOI: 10.1016/j.cell.2015.08.016. View

10.

Spiegel S, Maczis M, Maceyka M, Milstien S . New insights into functions of the sphingosine-1-phosphate transporter SPNS2. J Lipid Res. 2019; 60(3):484-489. PMC: 6399492. DOI: 10.1194/jlr.S091959. View

11.

Tea M, Poonnoose S, Pitson S . Targeting the Sphingolipid System as a Therapeutic Direction for Glioblastoma. Cancers (Basel). 2020; 12(1). PMC: 7017054. DOI: 10.3390/cancers12010111. View

12.

Nishimura H, Akiyama T, Monobe Y, Matsubara K, Igarashi Y, Abe M . Expression of sphingosine-1-phosphate receptor 1 in mantle cell lymphoma. Mod Pathol. 2010; 23(3):439-49. DOI: 10.1038/modpathol.2009.194. View

13.

Scully T, Ettela A, LeRoith D, Gallagher E . Obesity, Type 2 Diabetes, and Cancer Risk. Front Oncol. 2021; 10:615375. PMC: 7884814. DOI: 10.3389/fonc.2020.615375. View

14.

Kobayashi T, Lam P, Jiang H, Bednarska K, Gloury R, Murigneux V . Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environment. Blood. 2020; 136(26):3004-3017. DOI: 10.1182/blood.2020005602. View

15.

Sukocheva O, Furuya H, Ng M, Friedemann M, Menschikowski M, Tarasov V . Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target. Pharmacol Ther. 2019; 207:107464. DOI: 10.1016/j.pharmthera.2019.107464. View

16.

Rodriguez Y, Campos L, Castro M, Aladhami A, Oskeritzian C, Alvarez S . Sphingosine-1 Phosphate: A New Modulator of Immune Plasticity in the Tumor Microenvironment. Front Oncol. 2016; 6:218. PMC: 5066089. DOI: 10.3389/fonc.2016.00218. View

17.

Cheng J, Wang E, Yi Y, Thakur A, Tsai S, Hoodless P . S1P Stimulates Proliferation by Upregulating CTGF Expression through S1PR2-Mediated YAP Activation. Mol Cancer Res. 2018; 16(10):1543-1555. DOI: 10.1158/1541-7786.MCR-17-0681. View

18.

Sarkar S, Kumari D, Gupta S, Sharma V, Mukhi S, Kamboj P . Saroglitazar and Hepano treatment offers protection against high fat high fructose diet induced obesity, insulin resistance and steatosis by modulating various class of hepatic and circulating lipids. Biomed Pharmacother. 2021; 144:112357. DOI: 10.1016/j.biopha.2021.112357. View

19.

Singh S, Spiegel S . Sphingosine-1-phosphate signaling: A novel target for simultaneous adjuvant treatment of triple negative breast cancer and chemotherapy-induced neuropathic pain. Adv Biol Regul. 2019; 75:100670. DOI: 10.1016/j.jbior.2019.100670. View

20.

Weigert A, Weis N, Brune B . Regulation of macrophage function by sphingosine-1-phosphate. Immunobiology. 2009; 214(9-10):748-60. DOI: 10.1016/j.imbio.2009.06.003. View